Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

84.49

+3.82 (4.74%)

At close: Feb 6, 2026, 4:00 PM EST

84.46

-0.03 (-0.04%)

After-hours: Feb 6, 2026, 7:33 PM EST

Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,282	2,300	1,323	537	1,632	867
Market Cap Growth	134.46%	73.94%	146.40%	-67.12%	88.22%	352.15%
Enterprise Value	4,614	1,728	1,002	274	1,286	674
Last Close Price	84.49	38.60	22.93	10.91	34.20	20.16
PE Ratio	117.31	8.36	-	-	-	-
PS Ratio	25.50	5.30	22.04	20.19	59.67	30.29
PB Ratio	8.17	3.41	3.93	2.49	5.44	3.10
P/TBV Ratio	8.18	3.41	3.93	2.49	5.44	3.10
P/FCF Ratio	82.90	12.59	-	-	-	-
P/OCF Ratio	80.68	12.49	-	-	-	-
EV/Sales Ratio	22.05	3.98	16.69	10.29	47.01	23.53
EV/EBITDA Ratio	230.35	6.81	-	-	-	-
EV/EBIT Ratio	242.73	6.84	-	-	-	-
EV/FCF Ratio	72.42	9.45	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.00	0.02	0.02	0.02
Debt / EBITDA Ratio	0.47	0.04	-	-	-	-
Debt / FCF Ratio	0.17	0.06	-	-	-	-
Asset Turnover	0.32	0.79	0.20	0.09	0.08	0.12
Quick Ratio	12.94	12.39	16.54	7.61	7.55	7.69
Current Ratio	13.05	12.48	16.71	7.80	7.74	7.84
Return on Equity (ROE)	7.80%	54.39%	-28.59%	-49.41%	-43.32%	-36.79%
Return on Assets (ROA)	1.82%	28.66%	-19.32%	-27.57%	-23.40%	-16.82%
Return on Invested Capital (ROIC)	19.22%	189.05%	-	-	-	-
Return on Capital Employed (ROCE)	2.90%	36.30%	-27.80%	-60.60%	-41.40%	-22.70%
Earnings Yield	0.87%	11.96%	-5.97%	-23.73%	-7.69%	-7.63%
FCF Yield	1.21%	7.95%	-5.36%	-20.29%	-6.68%	-8.41%
Buyback Yield / Dilution	-0.97%	-14.65%	-15.74%	-5.87%	-34.67%	-32.84%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q